A case of chronic actinic dermatitis that responded completely to treatment with oral colostrum‐macrophage‐activating factor (colostrum‐ MAF )-Reference-Cited by-同舟云学术

A case of chronic actinic dermatitis that responded completely to treatment with oral colostrum‐macrophage‐activating factor (colostrum‐ MAF )

Published:2019-04-29 Issue:4 Volume:35 Page:290-292
ISSN:0905-4383
Container-title:Photodermatology, Photoimmunology & Photomedicine
language:en
Short-container-title:Photodermatol Photoimmunol Photomed

Author:

Ichihashi Masamitsu¹^ORCID,Nakamura Yoshitaka²,Muto Masahiko³,Nishikata Takahito⁴,Inui Tosio⁵,Uto Yoshihiro⁶

Affiliation:

1. Arts Ginza Clinic Tokyo Japan

2. Department of Dermatology Yamaguchi University Ube Japan

3. Department of Dermatology Ube‐Kosan Central Hospital Ube Japan

4. Graduate of Frontiers of Innovative Research in Science and Technology (FIRST) Konan University Kobe Japan

5. Saisei Mirai Clinic Kobe Kobe Japan

6. Graduate School of Technology, Industrial and Social Sciences Tokushima University Tokushima Japan

Publisher

Wiley

Subject

Dermatology,Radiology, Nuclear Medicine and imaging,Immunology,General Medicine,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/phpp.12469

Reference8 articles.

1. The IgA system: a comparison of structure and function in different species

2. Glycosylation of Immunoglobulin A Influences Its Receptor Binding

3. Degalactosylated/desialylated bovine colostrums induces macrophage phagocytic activity independently of inflammatory cytokine production;Uto Y;Anticancer Res,2015

4. Chronic actinic dermatitis: an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema;Hawk JLM;Br J Dermatol,1979

5. Chronic actinic dermatitis in a young patient with atopic dermatitis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Photosensitivity Diseases;Rook's Textbook of Dermatology;2024-03-19

2. Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib;Clinical, Cosmetic and Investigational Dermatology;2024-02

3. Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial;Biomedicine & Pharmacotherapy;2023-12

4. A convergent synthetic platform of hydrogels enclosing prednisolone-loaded nanoparticles for the treatment of chronic actinic dermatitis;Materials Technology;2023-06-10

5. Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature;Clinical, Cosmetic and Investigational Dermatology;2021-12